NCT06970236 Resistance Exercise in Patients With Ocular Melanoma
| NCT ID | NCT06970236 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Valencia |
| Condition | Ocular Melanoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-02-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-02-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Choroidal melanoma (CM) is one of the most common intraocular cancers worldwide. During treatment with episcleral brachytherapy, patients require a week of hospitalization in isolation. The primary aim of this study will be to investigate the effects of resistance training during hospitalization on health-related blood biomarkers in CM patients. Our secondary aim will be to assess changes in physical function tests, quality of life and anxiety and depression. Candidates for this study will be patients undergoing CM treatment at the "Hospital Universitari i Politècnic La Fe" of Valencia.
Eligibility Criteria
Inclusion Criteria: * Adults with Choroidal Melanoma diagnose and treated with plaque brachytherapy undergoing in "Hospital Universitari i Politècnic La Fe" (Valencia). Exclusion Criteria: * Present a health status that forbids high intensity resistance training. * Have any unsteady cardiac illness. * Have serious metabolic disorder. * Have any important orthopaedic disorder impeding exercise.
Frequently Asked Questions
Who can join the NCT06970236 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ocular Melanoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06970236 currently recruiting?
Yes, NCT06970236 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Valencia to inquire about joining.
Where is the NCT06970236 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06970236 clinical trial?
NCT06970236 is sponsored by University of Valencia. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.